Semaglutide and Vascular Regeneration

Clinical trial NCT05870462 · UNKNOWN

Trial details

NCT number: NCT05870462
Sponsor: Canadian Medical and Surgical Knowledge Translation Research Group
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Atherosclerosis Cardiovascular Diseases Diabetes Mellitus, Type 2 Obesity

Start date: 2023-04-29
Primary completion: 2024-12-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.